A second covid-19 vaccine has shown to be almost 95 per cent effective.
US company Moderna plans to apply for approval for it's vaccine in the coming weeks.
Just a week after Pfizer and BioNTech said their vaccine was over 90% effective, Moderna has published an early analysis of it's trial.
30 thousand participants in the US were given two doses of either the vaccine or a placebo four weeks apart.
Of the first 95 people to develop covid symptoms, just 5 had been given the vaccine, which means it is 94.5 per cent effective.
The news will add to the confidence that a vaccine can help end the pandemic.
It comes at a time when Ireland is experiencing a worrying development.
The 5 day moving average has began to persistently increase.